
Rupal S. Bhatt, MD, PhD, discusses the potential identification of a pathway of resistance for PD-L1 in renal cell carcinoma.

Your AI-Trained Oncology Knowledge Connection!


Published: October 2nd 2019 | Updated:

Published: October 25th 2019 | Updated: